Please login to the form below

Not currently logged in
Email:
Password:

UDG Healthcare acquires two New-York-based healthcare agencies

Offers a combined total of $82.4m for Create NYC and SmartAnalyst

UDG HealthcareHealthcare services provider UDG Healthcare has acquired two New-York based agencies earlier this week, offering a collective sum of up to $82.4m.

The Dublin-headquartered company operates across three divisions – Ashfield, Sharp and Aquilant – and currently employs 9,000 people with operations in 24 countries.

It has recently expanded its US footprint however, with its newly-acquired creative communications agency CreateNYC.

That business will soon operate as a division of Ashfield - UDG's healthcare communications arm.

Founded in 2009 by Natalie McDonald – who will remain with the company as its chief executive following its transition – CreateNYC employs 43 people and offers execution of sales and marketing materials for its pharmaceutical clients.

Meanwhile, UDG Healthcare’s additional acquisition SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies.

It was founded in 2001 and has grown to house 135 employees based in multiple countries, including London and New York.

The company also offers clients Health Economic and Outcomes Research (HEOR) services, a function that is in line with Ashfield’s strategy to expand its advisory service.

Commenting on the new purchases, Brendan McAtamney (pictured) chief executive of UDG Healthcare said: “These two acquisitions further expand the services we offer our healthcare clients.

Brendan Mcatamney

“CreateNYC adds innovative, creative services within Ashfield Communications while SmartAnalyst expands Ashfield’s advisory pillar, adding new capabilities in strategic consulting and HEOR.

“Both transactions meet all of UDG’s acquisition criteria – they are a good strategic and cultural fit; meet our target financial hurdle rates and involves an expansion of our current capabilities.”

Following the news, the FTSE 250 company’s share price rose by 2%.

Article by
Gemma Jones

6th July 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics